Preparing for the Future: AI Governance in Medical Device Procurement

The landscape for medical device manufacturers is rapidly changing, and those brisk changes are primarily influenced by the increasing integration of artificial intelligence (AI) into healthcare technologies. According to DQS, a globally recognized provider of auditing and certification services, it's becoming crucial for medical device manufacturers not just to secure regulatory approvals but also to align with evolving customer procurement expectations, particularly regarding cybersecurity and responsible AI governance.

The Shift in Procurement Expectations

With organizations like hospitals and health systems increasingly focusing on ensuring the safety and reliability of connected medical devices, the procurement process is beginning to incorporate more stringent evaluation criteria. Organizations seek assurances that both the devices themselves and the AI technologies powering them are adequately protected and responsibly governed before they are adopted for patient use. The emergence of AI governance as a central theme in procurement signifies a need for manufacturers to adapt their strategies accordingly.

Dr. Yuan Li, DQS’s Director of Medical Business, emphasizes that while regulatory compliance has always been a requirement, vendors now must also demonstrate their capabilities in governance and risk management related to AI models. This necessity is further underscored by a worrying trend—cybersecurity happenings within the medical technology sector that can delay product availability or disrupt care delivery.

Cybersecurity as a Foundation

The procurement baseline expectation for cybersecurity has intensified, especially as healthcare organizations now routinely assess vendors' information security systems. Frameworks like ISO 27001, which governs information security, are essential for differentiating vendors in this competitive landscape. However, with the increasing presence of AI in medical devices, the discussion around cybersecurity must deepen to include AI governance dimensions.

Governance Frameworks for AI Technologies

As organizations turn to AI-enabled tools for diagnostics, monitoring, and clinical support, the questions being posed to manufacturers are not merely centered on data protection. They extend to how these companies are managing their AI systems—from addressing potential biases within AI algorithms to ensuring adequate transparency and human accountability throughout the AI lifecycle. The introduction of ISO 42001, which offers a framework for establishing robust AI governance processes, is becoming increasingly valuable in this regard, despite not being mandated yet.

Dr. Li points out that while ISO 27001 helps with information security, it doesn’t encompass the sophisticated risks introduced by AI technologies. Issues such as model bias and oversight need tailored governance frameworks, and ISO 42001 is designed to provide a pathway for that.

Responding to Market Trends

Though ISO 42001 is not currently required for most manufacturers, DQS asserts that market expectations will likely drive its adoption well before any formal regulations emerge. This proactive mindset is crucial; companies that delay addressing these emerging practices may find themselves lagging behind as procurement standards are established. Today's healthcare organizations are not merely waiting for regulations—they are actively shaping the practices that determine vendor evaluation criteria.

Being Proactive in AI Governance

As the landscape of healthcare continues to evolve with rapid AI adoption, DQS urges medical device manufacturers to commence assessments of their AI governance methods. By integrating these with their existing quality, cybersecurity, and risk management systems, they can better ensure competitiveness in their marketplaces. Those who embrace this mindset will be well-positioned as customer expectations advance and mature.

DQS, which has accrued decades of experience providing guidance across multiple industries, stands as a valuable partner for organizations navigating the often-complex waters of evolving global standards such as ISO/IEC 27001 and the emerging relevance of ISO/IEC 42001.

Conclusion

The push towards effective AI governance and robust cybersecurity isn't merely about compliance; it's a strategic imperative in today’s healthcare procurement landscape. Manufacturers that act preemptively will find themselves aligning smoothly with the transformations shaping the future of medical technology.